Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses

Virology

Volumn 408, Issue 2, 2010, Pages 183-189

  Wright, Edward ^a   Hayman, David T S ^b,c,d   Vaughan, Aisling ^a,i   Temperton, Nigel J ^e   Wood, James L N ^c   Cunningham, Andrew A ^d   Suu Ire, Richard ^f,g   Weiss, Robin A ^a   Fooks, Anthony R ^b,h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF ZOOLOGY   (United Kingdom)

^e UNIVERSITY OF KENT   (United Kingdom)

^f Ministry of Food and Agriculture Ghana   (Ghana)

^g Wildlife Division of the Ghana Forestry Commission   (Ghana)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Africa; Antibody; Bat; Ghana; Lagos bat virus; Lyssavirus; Neutralisation; Pseudotype; Rabies virus; Serology

Indexed keywords

ANIMAL CELL; ANTIBODY TITER; ARTICLE; BAT; CELL STRAIN BHK; CELL STRAIN HEK293; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GHANA; HUMAN; HUMAN CELL; INFECTION RATE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; PSEUDOTYPING; RABIES VIRUS; SEROLOGY; SEROPREVALENCE; SPECIES DIFFERENCE; VALIDATION PROCESS; VIRUS CARRIER; VIRUS INFECTION; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; BIOLOGICAL EVOLUTION; CHIROPTERA; COMMUNICABLE DISEASES, EMERGING; DISEASE RESERVOIRS; FEMALE; GHANA; HEK293 CELLS; HUMANS; LYSSAVIRUS; MALE; NEUTRALIZATION TESTS; RHABDOVIRIDAE INFECTIONS; SPECIES SPECIFICITY;

EIDOLON HELVUM; LAGOS BAT VIRUS; LYSSAVIRUS; MEGACHIROPTERA; MOKOLA VIRUS; RABIES VIRUS; WEST CAUCASIAN BAT VIRUS;

EID: 78149412070     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.09.014     Document Type: Article

References (65)

1. Alberini I., Del Tordello E., Fasolo A., Temperton N.J., Galli G., Gentile C., Montomoli E., Hilbert A.K., Banzhoff A., Del Giudice G., Donnelly J.J., Rappuoli R., Capecchi B. Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses. Vaccine 2009, 27(43):5998-6003.
2. Aljofan M., Sganga M.L., Lo M.K., Rootes C.L., Porotto M., Meyer A.G., Saubern S., Moscona A., Mungall B.A. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro. Virol. J. 2009, 6:187.
3. Badrane H., Bahloul C., Perrin P., Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 2001, 75(7):3268-3276.
4. Banyard A.C., Johnson N., Voller K., Hicks D., Nunez A., Hartley M., Fooks A.R. Repeated detection of European bat lyssavirus type 2 in dead bats found at a single roost site in the UK. Arch. Virol. 2009, 154(11):1847-1850.
5. Banyard A.C., Hartley M., Fooks A.R. Reassessing the risk from rabies: a continuing threat to the UK?. Virus Res. 2010, 152(1-2):79-84.
6. Belikov S.I., Leonova G.N., Kondratov I.G., Romanova E.V., Pavlenko E.V. Isolation and genetic characterisation of a new lyssavirus strain in the Primorskiy kray. East Siberian J. Infect. Pathol. 2009, 16(3):68-69.
7. Belotto A., Leanes L.F., Schneider M.C., Tamayo H., Correa E. Overview of rabies in the Americas. Virus Res. 2005, 111(1):5-12.
8. Botvinkin A.D., Poleschuk E.M., Kuzmin I.V., Borisova T.I., Gazaryan S.V., Yager P., Rupprecht C.E. Novel lyssaviruses isolated from bats in Russia. Emerg. Infect. Dis. 2003, 9(12):1623-1625.
9. Boulger L.R., Porterfield J.S. Isolation of a virus from Nigerian fruit bats. Trans. R. Soc. Trop. Med. Hyg. 1958, 52(5):421-424.
10. Brookes S.M., Aegerter J.N., Smith G.C., Healy D.M., Jolliffe T.A., Swift S.M., Mackie I.J., Pritchard J.S., Racey P.A., Moore N.P., Fooks A.R. European bat lyssavirus in Scottish bats. Emerg. Infect. Dis. 2005, 11(4):572-578.
11. Cleaveland S. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 20 March 1997. Epidemiology and control of rabies. The growing problem of rabies in Africa. Trans. R. Soc. Trop. Med. Hyg. 1998, 92(2):131-134.
12. Cliquet F., Aubert M., Sagne L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods 1998, 212(1):79-87.
13. Corti D., Suguitan A.L., Pinna D., Silacci C., Fernandez-Rodriguez B.M., Vanzetta F., Santos C., Luke C.J., Torres-Velez F.J., Temperton N.J., Weiss R.A., Sallusto F., Subbarao K., Lanzavecchia A. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 2010.
14. Delmas O., Holmes E.C., Talbi C., Larrous F., Dacheux L., Bouchier C., Bourhy H. Genomic diversity and evolution of the lyssaviruses. PLoS ONE 2008, 3(4):e2057.
15. Demaison C., Parsley K., Brouns G., Scherr M., Battmer K., Kinnon C., Grez M., Thrasher A.J. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 2002, 13(7):803-813.
16. Dzikwi A.A., Kuzmin I.I., Umoh J.U., Kwaga J.K., Ahmad A.A., Rupprecht C.E. Evidence of Lagos bat virus circulation among Nigerian fruit bats. J. Wildl. Dis. 2010, 46(1):267-271.
17. Fooks A. The challenge of new and emerging lyssaviruses. Expert Rev. Vaccin. 2004, 3(4):333-336.
18. Fooks A.R., McElhinney L.M., Pounder D.J., Finnegan C.J., Mansfield K., Johnson N., Brookes S.M., Parsons G., White K., McIntyre P.G., Nathwani D. Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J. Med. Virol. 2003, 71(2):281-289.
19. Fraser G.C., Hooper P.T., Lunt R.A., Gould A.R., Gleeson L.J., Hyatt A.D., Russell G.M., Kattenbelt J.A. Encephalitis caused by a Lyssavirus in fruit bats in Australia. Emerg. Infect. Dis. 1996, 2(4):327-331.
20. Freuling C., Vos A., Johnson N., Fooks A.R., Muller T. Bat rabies-a Gordian knot?. Berl. Münch. Tierärztl. Wochenschr. 2009, 122(11-12):425-433.
21. Garcia J.M., Lagarde N., Ma E.S., de Jong M.D., Peiris J.S. Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay. J. Clin. Virol. 2009, 47(1):29-33.
22. Hanlon C.A., Kuzmin I.V., Blanton J.D., Weldon W.C., Manangan J.S., Rupprecht C.E. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 2005, 111(1):44-54.
23. Hayman D.T., Fooks A.R., Horton D., Suu-Ire R., Breed A.C., Cunningham A.A., Wood J.L. Antibodies against Lagos bat virus in megachiroptera from West Africa. Emerg. Infect. Dis. 2008, 14(6):926-928.
24. Hayman D.T., Suu-Ire R., Breed A.C., McEachern J.A., Wang L., Wood J.L., Cunningham A.A. Evidence of henipavirus infection in West African fruit bats. PLoS One 2008, 3(7):e2739.
25. Hayman D.T., Emmerich P., Yu M., Wang L.F., Suu-Ire R., Fooks A.R., Cunningham A.A., Wood J.L. Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One 2010, 5(8):e11978.
26. Johnson N., McElhinney L.M., Smith J., Lowings P., Fooks A.R. Phylogenetic comparison of the genus Lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genes. Arch. Virol. 2002, 147(11):2111-2123.
27. Johnson N., Vos A., Freuling C., Tordo N., Fooks A.R., Muller T. Human rabies due to lyssavirus infection of bat origin. Vet. Microbiol. 2010, 142(3-4):151-159.
28. Kemp G.E., Causey O.R., Moore D.L., Odelola A., Fabiyi A. Mokola virus. Further studies on IbAn 27377, a new rabies-related etiologic agent of zoonosis in nigeria. Am. J. Trop. Med. Hyg. 1972, 21(3):356-359.
29. King A.A., Meredith C.D., Thomson G.R. Canid and viverrid rabies viruses in South Africa. Onderstepoort J. Vet. Res. 1993, 60(4):295-299.
30. King A.A., Meredith C.D., Thomson G.R. The biology of southern African lyssavirus variants. Curr. Top. Microbiol. Immunol. 1994, 187:267-295.
31. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., Shaw A., Zinsstag J., Meslin F.X. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 2005, 83(5):360-368.
32. Kuzmin I.V., Hughes G.J., Botvinkin A.D., Orciari L.A., Rupprecht C.E. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 2005, 111(1):28-43.
33. Kuzmin I.V., Niezgoda M., Franka R., Agwanda B., Markotter W., Beagley J.C., Urazova O.Y., Breiman R.F., Rupprecht C.E. Lagos bat virus in Kenya. J. Clin. Microbiol. 2008, 46(4):1451-1461.
34. Kuzmin I.V., Niezgoda M., Franka R., Agwanda B., Markotter W., Beagley J.C., Urazova O.Y., Breiman R.F., Rupprecht C.E. Possible emergence of West Caucasian bat virus in Africa. Emerg. Infect. Dis. 2008, 14(12):1887-1889.
35. Kuzmin I.V., Wu X., Tordo N., Rupprecht C.E. Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions. Virus Res. 2008, 136(1-2):81-90.
36. Kuzmin I.V., Novella I.S., Dietzgen R.G., Padhi A., Rupprecht C.E. The rhabdoviruses: biodiversity, phylogenetics, and evolution. Infect. Genet. Evol. 2009, 9(4):541-553.
37. Kuzmin I.V., Mayer A.E., Niezgoda M., Markotter W., Agwanda B., Breiman R.F., Rupprecht C.E. Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res. 2010, 149(2):197-210.
38. Mallewa M., Fooks A.R., Banda D., Chikungwa P., Mankhambo L., Molyneux E., Molyneux M.E., Solomon T. Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg. Infect. Dis. 2007, 13(1):136-139.
39. Markotter W., Kuzmin I., Rupprecht C.E., Nel L.H. Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy. Virus Res. 2008, 135(1):10-21.
40. Mickleburgh S., Waylen K., Racey P. Bats as bushmeat: a global review. Oryx 2009, 43(2):217-234.
41. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272(5259):263-267.
42. Neil S., Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 2009, 29(9):569-580.
43. Nel L.H., Rupprecht C.E. Emergence of lyssaviruses in the Old World: the case of Africa. Curr. Top. Microbiol. Immunol. 2007, 315:161-193.
44. Nel L., Jacobs J., Jaftha J., von Teichman B., Bingham J., Olivier M. New cases of Mokola virus infection in South Africa: a genotypic comparison of Southern African virus isolates. Virus Genes 2000, 20(2):103-106.
45. Parry C.M., Kohli A., Boinett C.J., Towers G.J., McCormick A.L., Pillay D. Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1. J. Virol. 2009, 83(18):9094-9101.
46. Sabeta C.T., Bingham J., Nel L.H. Molecular epidemiology of canid rabies in Zimbabwe and South Africa. Virus Res. 2003, 91(2):203-211.
47. Sabeta C.T., Markotter W., Mohale D.K., Shumba W., Wandeler A.I., Nel L.H. Mokola virus in domestic mammals, South Africa. Emerg. Infect. Dis. 2007, 13(9):1371-1373.
48. Shope R.E., Murphy F.A., Harrison A.K., Causey O.R., Kemp G.E., Simpson D.I., Moore D.L. Two African viruses serologically and morphologically related to rabies virus. J. Virol. 1970, 6(5):690-692.
49. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305(5682):371-376.
50. Streicker D.G., Turmelle A.S., Vonhof M.J., Kuzmin I.V., McCracken G.F., Rupprecht C.E. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 2010, 329(5992):676-679.
51. Su C.Y., Wang S.Y., Shie J.J., Jeng K.S., Temperton N.J., Fang J.M., Wong C.H., Cheng Y.S. In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. Antivir. Res. 2008, 79(3):199-205.
52. Szecsi J., Boson B., Johnsson P., Dupeyrot-Lacas P., Matrosovich M., Klenk H.D., Klatzmann D., Volchkov V., Cosset F.L. Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses. Virol. J. 2006, 3:70.
53. Szecsi J., Gabriel G., Edfeldt G., Michelet M., Klenk H.D., Cosset F.L. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus. J. Infect. Dis. 2009, 200(2):181-190.
54. Teeling E.C., Springer M.S., Madsen O., Bates P., O'Brien S.J., Murphy W.J. A molecular phylogeny for bats illuminates biogeography and the fossil record. Science 2005, 307(5709):580-584.
55. Temperton N.J., Chan P.K., Simmons G., Zambon M.C., Tedder R.S., Takeuchi Y., Weiss R.A. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg. Infect. Dis. 2005, 11(3):411-416.
56. Temperton N.J., Hoschler K., Major D., Nicolson C., Manvell R., Hien V.M., Ha D.Q., Jong M.D., Zambon M., Takeuchi Y., Weiss R.A. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Respir. Viruses 2007, 1(3):105-112.
57. van Thiel P.P., van den Hoek J.A., Eftimov F., Tepaske R., Zaaijer H.J., Spanjaard L., de Boer H.E., van Doornum G.J., Schutten M., Osterhaus A., Kager P.A. Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: The Netherlands, December 2007. Euro Surveill. 2008, 13(2).
58. Vos A., Kaipf I., Denzinger A., Fooks A.R., Johnson N., Muller T. European Bat Lyssaviruses-an ecological enigma. Acta Chiropterol. 2007, 9(1):283-296.
59. Wang W., Xie H., Ye Z., Vassell R., Weiss C.D. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. J. Virol. Methods 2010, 165(2):305-310.
60. Warrilow D. Australian bat lyssavirus: a recently discovered new rhabdovirus. Curr. Top. Microbiol. Immunol. 2005, 292:25-44.
61. World-Health-Organisation (2008). Rabies. Fact Sheet No. 99.
62. Wright E., Temperton N.J., Marston D.A., McElhinney L.M., Fooks A.R., Weiss R.A. Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J. Gen. Virol. 2008, 89(Pt 9):2204-2213.
63. Wright E., McNabb S., Goddard T., Horton D.L., Lembo T., Nel L.H., Weiss R.A., Cleaveland S., Fooks A.R. A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine 2009, 27(51):7178-7186.
64. Yang Z.Y., Wei C.J., Kong W.P., Wu L., Xu L., Smith D.F., Nabel G.J. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 2007, 317(5839):825-828.
65. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15(9):871-875.